The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma

Lauren Fishbein, Jaydira Del Rivero, Tobias Else, James R. Howe, Sylvia L. Asa, Debbie L. Cohen, Patricia L.M. Dahia, Douglas L. Fraker, Karyn A. Goodman, Thomas A. Hope, Pamela L. Kunz, Kimberly Perez, Nancy D. Perrier, Daniel A. Pryma, Mabel Ryder, Aaron R. Sasson, Michael C. Soulen, Camilo Jimenez

Research output: Contribution to journalArticlepeer-review

Abstract

This manuscript is the result of the North American Neuroendocrine Tumor Society consensus conference on the medical management and surveillance of metastatic and unresectable pheochromocytoma and paraganglioma held on October 2 and 3, 2019. The panelists consisted of endocrinologists, medical oncologists, surgeons, radiologists/nuclear medicine physicians, nephrologists, pathologists, and radiation oncologists. The panelists performed a literature review on a series of questions regarding the medical management of metastatic and unresectable pheochromocytoma and paraganglioma as well as questions regarding surveillance after resection. The panelists voted on controversial topics, and final recommendations were sent to all panel members for final approval.

Original languageEnglish (US)
Pages (from-to)469-493
Number of pages25
JournalPancreas
Volume50
Issue number4
DOIs
StatePublished - 2021

Keywords

  • management
  • metastatic paraganglioma
  • metastatic pheochromocytoma
  • surveillance
  • treatment

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Fingerprint

Dive into the research topics of 'The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma'. Together they form a unique fingerprint.

Cite this